The arylpyrroles 40-43 were prepared by 5-exo-trig cyclization 9) of the a-cyano-g-keto esters 32-34, 36 with gaseous HCl in Et 2 O. Pyrrole 44 was synthesized by hydride hydrogenolysis of 43 using ammonium formate in the presence of palladium on carbon. The a-cyano-g-keto esters 32, 10) 33 and 34 10) were obtained together with the bis alkylating products 37-39 by alkylation of ethyl cyanoacetate with known or commercially available bromides 29, 11) 30, 11) 31 and K 2 CO 3 in acetone. Interestingly, nitration of 34 with potassium nitrate in concentrate sulphuric acid produced the m-nitrophenyl-g-keto-a-carbamoyl-ester which was dehydrated to give the desired cyanoketoester 36. Final alkaline hydrolysis of 40-44 afforded the acids 6-9.
The other key intermediate, the pyridylpiperazine 10 was prepared in a fashion similar to that reported previously 12) and it is shown in Chart 5. However, we optimized the nucleophilic aromatic substitution as follows: the 2-chloro-3-nitropyridine 46 was reacted with 10 eq of piperazine in the presence of diisopropylethylamine furnishing a mixture of 1-(3-nitro-2-pyridyl)piperazine 47 13) (60%) and of bis-substituted derivative 48 14) (15%), which were resolved by Al 2 O 3 chromatography eluting with CHCl 3 . Protection of the remaining free nitrogen of 47 as tert-butyl-carbamate, and subsequent hydrogenation, reductive alkylation, and deprotection provided the desired N-isopropyl-N-(2-piperazine-3-pyridyl)amine 10 as already reported.
12)

Results and Discussion
The newly synthesized delavirdine analogues 1 were eval-uated for their inhibitory effects against the HIV-1 multiplication in acutely infected MT 4 cells (Table 1) . Under our assay conditions, some of the new compounds, elicited significant anti-HIV-1 activities, with effective concentration (EC 50 ) values ranging from 0.25 to 10 mM (1Aa, 1Ad, 1Ae, 1Ab).
The most potent compound in this series was compound 1Aa and it could represent an interesting hit which could further optimized. The effect of 1Aa on the multiplication of NNRTI-resistant mutant viruses possessing the amino acid substitutions K103R, Y181C or the double substitution K103N-Y181C is shown in Table 2 . Unfortunately, compound 1Aa was inactive against the above mutant variants.
On the basis of the results reported in Table 1 , several comments can be made. In general the presence of a carbonyl group linked at the a position of the pyrrole ring correlates with significant anti-HIV-1 activity (compounds 1A). In fact, derivatives bearing the same junction on the pyrrole b carbon (compounds 1B) were devoid of antiretroviral activity, with the sole exception of compounds 1Bf and 1Bg. Among compounds 1A, high anti-HIV-1 activity is correlated with the presence of a polar group (NH 2 or CH 3 SO 2 NH) in the para position of the phenyl moiety.
Although compound 1Aa is less potent than delavirdine and, like this latter, is inactive against clinically relevant NNRTIs resistant mutants, we think to introduce further chemical modifications in order to obtain compounds with an enhanced potency against the above mutants.
Experimental
Chemistry. General Unless otherwise noted, all materials were obtained from commercial suppliers and used without purification. Anhydrous solvents were obtained from Aldrich in sure-seal bottles.
All reactions involving air-or moisture-sensitive compounds were performed under an argon atmosphere. Flash chromatography was performed using Merck Silica gel 60 (230-400 mesh ASTM).
Thin layer chromatography (TLC) was performed with Polygram ® SIL N-HR-/HV 254 precoated plastic sheet (0.2 mm). Chemical shifts are expressed in d (ppm) downfield from internal tetramethylsilane (TMS) and coupling costants in Hz. Significant 1 H-NMR data are reported in the following order: multiplicity (s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; dq, double quartet; dd, double doublet; br s, broad singlet), number of protons, and coupling costants in Hz. IR spectra were recorded as thin films (for oils) or Nujol mulls (for solids) on NaCl plates with a Perkin-Elmer 781 IR spectrophotometer and are expressed in n (cm
Ϫ1
). UV-Vis spectra were recorded as ethanolic solutions with a PerkinElmer Lambda 5 spectrophotometer and the absorption wavelengths are expressed in nm followed by (log e). Melting points were determined on a Thomas Hoover capillary melting point apparatus and are uncorrected. Elemental analyses were performed at Laboratory of Microanalysis, Department of Chemistry, University of Sassari (Italy), and are within Ϯ0.4% of the calculated values. The following known materials were prepared as described in the literature: 29, 11 tetrahydrofuran (THF) (6 ml) was stirred for 1 h at room temperature and under argon atmosphere. The reaction mixture was cooled to 0°C, and Nisopropyl-N-(2-piperazine-3-pyridyl)amine 10 12) (0.49 g, 2.22 mmol) in THF (7 ml) was added. The reaction was stirred for 12 h at room temperature, and poured into NaHCO 3 solution. The aqueous mixture was extracted with CH 2 [
4-[3-(Isopropylamino)-2-pyridyl]piperazino]-[5-(4-nitrophenyl)-1H-2-pyrrolyl]methanone (11)
12) (0.43 g, 1.95 mmol) and EDC (0.41 g, 2.12 mmol) in THF (6 ml) was stirred at room temperature for 12 h under argon atmosphere. The reaction mixture was poured into aqueous solution of NaHCO 3 and extracted with CHCl 3 . The organic layer was washed with brine, dried over MgSO 4 
N-[4-[5-([4-[3-(Isopropylamino)-2-pyridyl]piperazino]-carbonyl)-1H-2-pyrrolyl]phenyl]methansulfonamide (1Aa)
A mixture of 1Ad (0.14 g, 0.35 mmol), pyridine (0.056 ml, 0.69 mmol), and methanesulfonyl chloride (0.027 ml, 0.35 mmol) in CH 2 Cl 2 (1.5 ml) was stirred for 12 h at room temperature. The mixture was diluted with CH 2 Cl 2 (7.5 ml) and water (3 ml), the layers were separated and the organic layer was washed with brine, dried over Na 2 SO 4 , and evaporated in vacuo to give a crude brown oil. The resulting material was submitted to flash silica gel chromatography, eluting with 9 : 1 CHCl 3 : CH 3 OH to afford 0.11 g (64.7%) of 1Aa: Rf 0. 16 The following compounds (1Ab, 1Ac, 1Ba, 1Bb, 1Bc ) were prepared by a manner similar to that used for 1Aa. ganic layer was separated and washed successively with aqueous 10% NaH 2 PO 4 solution (35 ml) and brine (25 ml), dried over Na 2 SO 4 , and evaporated in vacuo to afford a oily product. The crude oil was submitted to "bulb to bulb" distillation at 70-80°C/(0.5 mmHg) to remove the excess of CNCH 2 COOEt and the residue subjected to flash silica gel chromatography, eluting with 7 : 3 petrol ether : EtOAc, to give 4.50 g (58.5%) of 32 from the first fraction as a yellow oil which on standing solidified; mp 80-82°C 2 Cl 2 (10 ml), POCl 3 (5 ml) was added dropwise at 0°C. Then the reaction mixture was refluxed for 5 h. After cooling, the mixture was poured onto ice, alkalinized with Na 2 CO 3 and extracted with CH 2 Cells and Viruses MT-4 and C8166 cells were grown at 37°C in a 5% CO 2 atmosphere in RPMI 1640 medium, supplemented with 10% fetal calf serum (FCS), 100 UI/ml penicillin G and 100 mg/ml streptomycin. Cell cultures were checked periodically for the absence of mycoplasma contamination with the MycoTect Kit (Gibco). HIV-1 was obtained from supernatants of persistently infected H9/III B cells. The Y181C mutant (NIH N119) was derived from an AZT-sensitive clinical isolate passaged in CEM cells in the presence of Nevirapine [10 mM] as described by Richman D. et al.
15) The K103R virus was derived from a III B strain passaged in C8166 cells in the presence of Efavirenz [2 mM] and the mutations (K103R, V179D, P225H) were identified by R. Schinazi at the Emory University of Georgia. The double mutant K103N-Y181C (NIH A17) was derived from a IIIB strain passaged in H9 cells in the presence of Nevirapine as described by Nunberg J. H. et al. 16) The HIV-1 wt and the mutant Y181C, K103R and K103N-Y181C stock solutions had titres of 1.0ϫ10 7 (wt) 50% cell culture infectious dose (CCID 50 )/ml, 1.3ϫ10 6 (Y181C) CCID 50 /ml, 3.0ϫ10 5 (K103R) CCID 50 /ml and 2.5ϫ10 5 (Y181C-K103N) CCID 50 /ml, respectively. HIV Titration Virus titration was performed in C8166 cells by the standard limiting dilution method (dilution 1 : 2, four replica wells/dilution) in 96-well plates. The infectious virus titre was determined by light microscope scoring of cytopathicity after 4 d of incubation, and virus titres were expressed as CCID 50 /ml.
Anti-HIV Assays Activity of the compounds against HIV-1 wt, the Y181C mutant and the double mutant K103N-Y181C were based on inhibition of virus-induced cytopathicity in MT-4 cells acutely infected at a multiplicity of infection of 0.01. Activity of compounds against the K103R were based on inhibition of p24 antigen in C8166 cells acutely infected at a m.o.i.ϭ0.01. 17) Briefly, 50 ml of culture medium containing 1ϫ10 4 cells were added to each well of flat-bottom microtitre trays containing 50 ml of culture medium with or without test compounds. Then 20 ml of an HIV suspension containing 100 (HIV-1) CCID 50 was added. After a 4-d incubation, cell viability was determined by 3-(4,5-dimethylthiazol-1-yl)-2,5-diphenyltetrazolium bromide (MTT) method. Alternatively, anti-HIV-1 activity was evaluated by reduction of p24 antigen production by ELISA test (Abbott). Cytotoxicity of test compounds was evaluated in parallel with their antiviral activity and was based on the viability of mock-infected cells, as monitored by the MTT method.
